KREBS BIOCHEMICALS & INDUSTRIES
Back to Cashflow Statement
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-7.89 Cr | ₹2.36 Cr | ₹-25 Cr | ₹-17 Cr | ₹-15 Cr |
What is the latest Cash Flow from Operating Activities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-7.89 Cr |
| Mar2024 | ₹2.36 Cr |
| Mar2023 | ₹-25 Cr |
| Mar2022 | ₹-17 Cr |
| Mar2021 | ₹-15 Cr |
How is Cash Flow from Operating Activities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.89 Cr | Negative | |
| Mar2024 | ₹2.36 Cr | Positive | |
| Mar2023 | ₹-25 Cr | Negative | |
| Mar2022 | ₹-17 Cr | Negative | |
| Mar2021 | ₹-15 Cr | - | |
Compare Cash Flow from Operating Activities of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹141.2 Cr | 13.3% | 2.1% | -22.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 13.3% |
2.1% |
-22.6% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses